Log In
Print
BCIQ
Print
Print this Print this
 

PT005

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionFormoterol fumarate, a long-acting adrenergic receptor beta 2 agonist (LABA) delivered via a metered-dose hydrofluoroalkane (HFA) inhaler
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD); Treat moderate to very severe chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today